Patents by Inventor Daise JIMÉNEZ RODRÍGUEZ

Daise JIMÉNEZ RODRÍGUEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF THE BASIC FORM OF RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF A PATIENTS WITH SPINOCEREBELLAR ATAXIA WITH CAG REPEAT MUTATIONS
    Publication number: 20210060127
    Abstract: The present invention relates to use of pharmaceutical compositions that have as active ingredient the basic form of recombinant human erythropoietin (rhEPO) and that are administered nasally for the treatment of spinocerebellar ataxia (SCA) with mutations of CAG repeats type, particularly of SCA type 2. Another object of the present invention is a method for stratifying patients into responders and non-responders to treatment with the basic form of rhEPO.
    Type: Application
    Filed: June 8, 2017
    Publication date: March 4, 2021
    Inventors: Daniel Enrique AMARO GONZÁLEZ, Luis Clodoaldo VELÁZQUEZ PÉREZ, Julio César GARCÍA RODRÍGUEZ, Roberto RODRÍGUEZ LABRADA, lliana María SOSA TESTÉ, Ricardo ORTEGA SÁNCHEZ, Patricia HERNÁNDEZ CASAÑA, Consuelo GONZÂLEZ TRIANA, Daniel JAY PÉREZ, Lien LÓPEZ MATILLA, Daise JIMÉNEZ RODRÍGUEZ